Adlai Nortye Ltd. Sample Contracts

ADLAI NORTYE LTD. AND THE BANK OF NEW YORK MELLON As Depositary AND OWNERS AND HOLDERS OF AMERICAN DEPOSITARY SHARES Deposit Agreement
Deposit Agreement • August 10th, 2023 • Adlai Nortye Ltd. • Pharmaceutical preparations • New York

DEPOSIT AGREEMENT dated as of __________, 2023 among ADLAI NORTYE LTD., a company incorporated under the laws of the Cayman Islands (herein called the Company), THE BANK OF NEW YORK MELLON, a New York banking corporation (herein called the Depositary), and all Owners and Holders (each as hereinafter defined) from time to time of American Depositary Shares issued hereunder.

AutoNDA by SimpleDocs
INDEMNIFICATION AGREEMENT
Indemnification Agreement • July 27th, 2023 • Adlai Nortye Ltd. • Pharmaceutical preparations

THIS INDEMNIFICATION AGREEMENT (this “Agreement”) is made as of ____________, by and between Adlai Nortye Ltd., an exempted company with limited liability duly incorporated and validly existing under the laws of the Cayman Islands (the “Company”), and __________(Passport/ID Number ____________) (the “Indemnitee”), a [director/an executive officer] of the Company.

EMPLOYMENT AGREEMENT
Employment Agreement • July 27th, 2023 • Adlai Nortye Ltd. • Pharmaceutical preparations • New York

This EMPLOYMENT AGREEMENT (the “Agreement”) is entered into as of _______________ , 2023 by and between Adlai Nortye Ltd., an exempted company incorporated and existing under the laws of the Cayman Islands (the “Company”) and _____________________, an individual with _______________ [passport/ID number] _________________________ (the “Executive”).

SUBSCRIPTION AGREEMENT
Subscription Agreement • July 27th, 2023 • Adlai Nortye Ltd. • Pharmaceutical preparations • New York

The Purchaser on the one hand, and the Company on the other hand, are sometimes herein referred to each as a “Party,” and collectively as the “Parties.”

ADLAI NORTYE LTD. [ · ] American Depositary Shares Representing [ · ] Ordinary Shares (par value $0.0001 per share) Underwriting Agreement
Underwriting Agreement • August 14th, 2023 • Adlai Nortye Ltd. • Pharmaceutical preparations • New York
LICENSE AGREEMENT
License Agreement • July 27th, 2023 • Adlai Nortye Ltd. • Pharmaceutical preparations • New York

This LICENSE AGREEMENT (this “License Agreement”) is made as of this 22 day of December, 2017 (“Execution Date”), by and between Novartis Pharma AG, a company organized under the laws of Switzerland and located at Lichtstrasse 35, 4056 Basel, Switzerland (“Novartis”), and Adlai Nortye BioPharma Co. Ltd., a limited company organized under the laws of the PRC (as defined below), with headquarters at 21 Floor, Building 2, No. 452, 6th Street, Hangzhou Eco. & Tech. Development Area, 31008, PRC (“Adlai Nortye”). Novartis and Adlai Nortye are each referred to individually as a “Party” and together as the “Parties.”

Right and Interest Transfer Agreement (Confidential)
Right and Interest Transfer Agreement • July 27th, 2023 • Adlai Nortye Ltd. • Pharmaceutical preparations

This Rights and Interests Transfer Agreement (hereinafter referred to as this “Agreement”) is entered into by and between the parties below on ___ (Date) of 2021:

OPTION AGREEMENT
Option Agreement • May 11th, 2023 • Adlai Nortye Ltd. • Pharmaceutical preparations • New York

This license agreement (this “License Agreement”) is made as of __, (“Effective Date”), by and between Nippon Kayaku Co., Ltd., a company organized under the laws of Japan and located at 1-1, Marunouchi 2-chome, Chiyoda-ku, Tokyo 100-0005, Japan (“Nippon Kayaku”), and Adlai Nortye Pte Ltd., a company organized under the laws of Singapore (as defined below) and located 77 Robinson Road, #20-01 Robinson 77, Singapore, 068896 (“Adlai Nortye”). Nippon Kayaku and Adlai Nortye are each referred to individually as a “Party” and together as the “Parties.”

EXCLUSIVE LICENSE AGREEMENT
Exclusive License Agreement • July 27th, 2023 • Adlai Nortye Ltd. • Pharmaceutical preparations • New York

This Exclusive License Agreement (this “Agreement”) is entered into as of January 19, 2018 (the “Effective Date”), between Adlai Nortye Biopharma Co., Ltd., a company organized and existing under the laws of People’s Republic of China, whose principal place of business is located at No. 452, 6th Street, Hangzhou Eco. & Tech. Development Zone, Zhejiang, P. R. China (“Adlai Nortye”)

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!